Stephanie Curry

Statistics

Publications

Citations

830

H-Index

Active since

2003

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

WuXi AppTec (China)

United States Military Academy

Southern Research Institute

Institute of Virology of the Slovak Academy of Sciences

Stephanie Curry is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in molecular virology, pharmacology, and antiviral agents.

ORCID

Publications per year

2003–2018

Publications

Regulation of Eotaxin Gene Expression by TNF-α and IL-4 Through mRNA Stabilization: Involvement of the RNA-Binding Protein HuR

Ulus Atasoy, Stephanie Curry, Isabel López de Silanes et al. · The Journal of Immunology · 2003 · 119 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Susceptibilities of Genotype 1a, 1b, and 3 Hepatitis C Virus Variants to the NS5A Inhibitor Elbasvir

Rong Liu, Stephanie Curry, Patricia McMonagle et al. · Antimicrobial Agents and Chemotherapy · 2015 · 77 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons

Frederick Lahser, Karin Bystol, Stephanie Curry et al. · Antimicrobial Agents and Chemotherapy · 2016 · 58 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3

Marcelo Silva, Michelle Treitel, Donald J. Graham et al. · Journal of Hepatology · 2013 · 56 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Functional Analysis of the Chemokine Receptor CCR3 on Airway Epithelial Cells

Lisa A. Beck, B. Tancowny, Mary Brummet et al. · The Journal of Immunology · 2006 · 53 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

1–5 of 24